Dimension Biotechnologies

Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer lining blood vessel walls whose biochemical integrity is disrupted early in cardiovascular disease, kidney disease, diabetes, and sepsis.

The platform detects glycocalyx biomarker signatures from a blood sample using spectroscopic methods compatible with existing laboratory equipment, enabling non-invasive assessment of microvascular health for clinical prognostics and drug development research.